Cointime

Regenosine, Inc

company

About

Regenosine is developing a first-in-class disease-modifying regenerative therapy for osteoarthritis.

  • 11 - 50

Highlights

Total Funding Amount
$1.67M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.67M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.67M
Regenosine, Inc has raised a total of $1.67M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2021 Grant $1.67M 1 National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Regenosine, Inc is funded by 1 investors. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) are the most recent investors.
Investor Name Lead Investor Funding Round
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Yes Grant
Cointime
เนื้อหา
บริษัท